Recent changes
Friday, March 13, 2026
NIH Reminder: IRB Approval Certification Required Before Award
The National Institutes of Health (NIH) issued a notice reminding the extramural research community that certification of Institutional Review Board (IRB) approval is required before award for nonexempt human subjects research. Funds cannot be used for such research without this certification, which must be the date of final IRB approval, not pending or expired.
NIH Removes Advanced Permission for Conference Grant Applications
The National Institutes of Health (NIH) has removed the requirement for advanced permission for conference grant applications under activity codes R13 and U13. This change aims to reduce administrative burden for applicants, with modifications to the NIH Grants Policy Statement and relevant NOFOs forthcoming.
NIH Correction: Salary Limitation for Grants and Cooperative Agreements FY 2026
The National Institutes of Health (NIH) issued a correction to its guidance on salary limitations for grants and cooperative agreements for Fiscal Year 2026. The correction adjusts the effective date for the Executive Level II salary limitation of $228,000 from January 11, 2026, to January 1, 2026.
NIH Extends Common Forms Timeline for Biographical Sketch and Other Support
The National Institutes of Health (NIH) has extended the leniency period for implementing Common Forms for Biographical Sketch and Current and Pending (Other) Support until May 2026. This notice adjusts the original January 25, 2026 deadline to allow the extramural community more time for adoption and compliance.
NIH Notice: Expiration of PAR-25-326 Ultra-Rare Gene Therapy Network Access
The National Institute of Neurological Disorders and Stroke (NINDS) issued a notice announcing the immediate expiration of Funding Opportunity Announcement PAR-25-326 for Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access. No further applications will be accepted under this announcement.
Wednesday, March 11, 2026
NIDA Funding Opportunity PAR-24-298 Expires Early
The National Institute on Drug Abuse (NIDA) has issued a notice announcing the immediate early expiration of the funding opportunity PAR-24-298, "Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)". No further applications will be accepted under this announcement.
NEI Seeks Feedback for 2026-2031 Strategic Plan
The National Eye Institute (NEI) is requesting feedback for its 2026-2031 Strategic Plan, which will guide vision research priorities. The NEI is seeking input from the scientific community, health professionals, patient advocates, and the public.
AHRQ Small Health Services Research Grant Program (R03) Expired
The Agency for Healthcare Research and Quality (AHRQ) has issued a notice announcing the immediate expiration of the Small Health Services Research Grant Program (R03) under Funding Opportunity Announcement PA-24-155. No further applications will be accepted for this program.
AHRQ Health Services Research Projects (R01) PA-24-154 Expired
The Agency for Healthcare Research and Quality (AHRQ) has issued a notice announcing the immediate expiration of Funding Opportunity Announcement PA-24-154 for Health Services Research Projects (R01). No further applications will be accepted under this announcement.
AHRQ Diagnostic Safety R01 Funding Opportunity PA-23-291 Expired
The Agency for Healthcare Research & Quality (AHRQ) has issued a notice announcing the early expiration of Funding Opportunity Announcement PA-23-291, which focused on understanding and improving diagnostic safety in ambulatory care. No further applications will be accepted under this announcement.
Last 7 days
Most active sources
Browse Categories
Activity
Get daily alerts
Morning digest delivered to your inbox. Free.
Free. Unsubscribe anytime.
4 monitored sources
Get NIH alerts
Daily digest of NIH regulatory changes. AI-summarized, no noise.
Free. Unsubscribe anytime.